SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-132567
Filing Date
2021-04-27
Accepted
2021-04-27 07:00:52
Documents
10
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d101035ddef14a.htm DEF 14A 425510
2 GRAPHIC g101035g01a20.jpg GRAPHIC 36937
3 GRAPHIC g101035g01c28.jpg GRAPHIC 251651
4 GRAPHIC g101035g02n44.jpg GRAPHIC 169274
5 GRAPHIC g101035g17p65.jpg GRAPHIC 69914
6 GRAPHIC g101035g38t37.jpg GRAPHIC 18190
7 GRAPHIC g101035g75z61.jpg GRAPHIC 67951
8 GRAPHIC g101035g80o53.jpg GRAPHIC 18823
9 GRAPHIC g101035g85b95.jpg GRAPHIC 57897
10 GRAPHIC g101035g99d47.jpg GRAPHIC 41477
  Complete submission text file 0001193125-21-132567.txt   1432150
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 21855835
SIC: 2834 Pharmaceutical Preparations